ライフサイエンスコーパス: coronary angiography

1 in a separate CKD cohort (n=220) undergoing coronary angiography.

2 HCA, 143688 (35.2%) were selected to undergo coronary angiography.

3 ing the frequency of nonobstructive invasive coronary angiography.

4 ca and enrolling 968 patients presenting for coronary angiography.

5 infusions of acetylcholine during diagnostic coronary angiography.

6 both cardiac magnetic resonance imaging and coronary angiography.

7 within 90 days than evaluation with invasive coronary angiography.

8 s with an intermediate degree of stenosis in coronary angiography.

9 tice paradigms to guide referral to invasive coronary angiography.

10 egional wall motion abnormalities but normal coronary angiography.

11 re obtained in 16 stable patients undergoing coronary angiography.

12 st was abnormal, patients underwent invasive coronary angiography.

13 k in a large cohort of patients referred for coronary angiography.

14 Fourteen patients subsequently underwent coronary angiography.

15 els were measured in 499 patients undergoing coronary angiography.

16 th study comprising 3307 patients undergoing coronary angiography.

17 to improve patient selection for diagnostic coronary angiography.

18 in patients with ASA sensitivity undergoing coronary angiography.

19 enerally considered for referral to invasive coronary angiography.

20 stenosis was defined as >50% by quantitative coronary angiography.

21 eported in 18% to 30% of patients undergoing coronary angiography.

22 patients had <50% stenosis (CAD-), based on coronary angiography.

23 (18)F-NaF and (18)F-FDG PET-CT, and invasive coronary angiography.

24 l strain echocardiography, exercise ECG, and coronary angiography.

25 cipients at the time of clinically-indicated coronary angiography.

26 important predictors of obstructive CAD with coronary angiography.

27 ency-domain optical coherence tomography and coronary angiography.

28 dergoing (82)Rb PET within 180 d of invasive coronary angiography.

29 4,829 of 22,538 patients (21.4%) had normal coronary angiography.

30 AR were measured in 3278 patients undergoing coronary angiography.

31 dolinium enhancement, and magnetic resonance coronary angiography.

32 in 41 subjects with chest pain scheduled for coronary angiography.

33 llow-up in 4007 patients undergoing elective coronary angiography.

34 probability underwent MDCT, CMR and invasive coronary angiography.

35 idney injury (CI-AKI) in patients undergoing coronary angiography.

36 scores among individuals who were undergoing coronary angiography.

37 the PA and the LMCA and underwent selective coronary angiography.

38 ation, 50 received ECLS, and all 55 received coronary angiography.

39 ) in the studied patients who underwent MSCT coronary angiography.

40 nts with stable angina referred for invasive coronary angiography.

41 atinine 1.5-3 mg/dL) who were candidates for coronary angiography.

42 line serum TMAO and long-term survival after coronary angiography.

43 heart failure undergoing elective diagnostic coronary angiography.

44 rm mortality in patients with CKD undergoing coronary angiography.

45 on computed tomography (SPECT), and invasive coronary angiography.

46 r the bioresorbable scaffold by quantitative coronary angiography (1.15 mm vs 1.46 mm, p<0.0001) and

47 Of these, 17 141 (65%) underwent coronary angiography, 12 183 (46.2%) underwent percutane

48 s. 9.1%), aspirin (12.7% vs. 8.5%), invasive coronary angiography (14.7% vs. 10.1%), and percutaneous

49 he CCTA arm had the highest rate of invasive coronary angiography (18%), whereas women had comparable

50 0.11-0.29], DSE 24 [95% CI, 0.10-0.38], and coronary angiography 20 [95% CI, 0.08-0.32; P = 0.91]).

51 For cTn+ AHFS, rates of coronary angiography (21.8 vs 11.4 patients/100 person-y

52 er they provided verbal assent and underwent coronary angiography, 296 patients in 7 U.K. centers wer

53 Coronary angiography, 3 minutes after injection, confirm

54 e tests (28% versus 17%; P=0.0009), invasive coronary angiography (31% versus 20%; P=0.0009), and rev

55 Coronary angiography (314 [35.0%] vs 925 [60.8%]; P < .0

56 went therapeutic hypothermia (97.7%), urgent coronary angiography (44.2%), and urgent percutaneous co

57 Of 16 646 patients who had inpatient coronary angiography, 58.5% underwent inpatient revascul

58 Furthermore, for diagnostic coronary angiography 5F instead of 4F introducer was use

59 2] years) were analyzed: 628 (35.6%) without coronary angiography, 615 (35.7%) with coronary angiogra

60 ac positron emission tomography and invasive coronary angiography, 92 patients with single- or 2-vess

61 ronary artery disease on subsequent invasive coronary angiography across CAC score strata (Agatston s

62 compared with those managed medically after coronary angiography (adjusted OR 0.66, 95%CI 0.57-0.77)

63 D, 23.8%]), number of patients with invasive coronary angiography after 12 months was 102 in the NICE

64 Among 247 subjects undergoing coronary angiography after resuscitation from a cardiac

65 All subjects undergoing coronary angiography after resuscitation from a cardiac

66 utive patients (n=329) referred for invasive coronary angiography after stress testing with myocardia

67 nts (n=329, 43% women) referred for invasive coronary angiography after stress testing with myocardia

68 he diagnostic accuracy in comparison with CT coronary angiography alone.

69 There was a trend toward more invasive coronary angiographies among patients undergoing coronar

70 ed to improve patient selection for emergent coronary angiography among resuscitated patients.

71 31 +/- 9 kg/m(2)) without known CAD (96 with coronary angiography and 38 with low pretest likelihood

72 ergoing TAVR, screening of CAD with invasive coronary angiography and ad hoc PCI during TAVR is feasi

73 ol subjects were identified from the Swedish Coronary Angiography and Angioplasty Register between 20

74 open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry for enroll

75 included from the nationwide SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

76 tents (o-DES) enrolled in the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

77 (61+/-9 years, 52% women) were included via coronary angiography and computed tomography as part of

78 ive patients who underwent both conventional coronary angiography and dual-source (256-slice) compute

79 After coronary angiography and echocardiography, all underwent

80 ndent core laboratory performed quantitative coronary angiography and evaluated all pressure tracings

81 508 patients (mean age, 62 y) who underwent coronary angiography and extensive clinical and radiogra

82 Consecutive patients who underwent CT coronary angiography and FFR assessment with one or more

83 ents were 48 patients who underwent invasive coronary angiography and had no known coronary artery di

84 ents were 48 patients who underwent invasive coronary angiography and had no known coronary artery di

85 ll as efficacy at 1 month using quantitative coronary angiography and histomorphometry.

86 When the Society of Coronary Angiography and Intervention definition of peri

87 composite end point of death, MI (Society of Coronary Angiography and Intervention definition), ische

88 l artery is now the most frequent access for coronary angiography and intervention.

89 ETHODS AND Serial (baseline and 6-12 months) coronary angiography and intravascular ultrasound were p

90 tudy of the prospective Combined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Us

91 ry assessment by clinical stratification and coronary angiography and of coronary intervention on pro

92 From 2000 to 2012, coronary angiography and PCI after VT/VF OHCA increased

93 uld suggest physicians to consider immediate coronary angiography and PCI if indicated in these patie

94 nts: An observational analysis of the use of coronary angiography and PCI in 407974 patients hospital

95 s was used to assess factors associated with coronary angiography and PCI use.

96 increasing frequency as the access point for coronary angiography and percutaneous coronary intervent

97 ends, predictors, and outcomes of performing coronary angiography and percutaneous coronary intervent

98 cardial infarction who were about to undergo coronary angiography and percutaneous coronary intervent

99 o radial (4197) or femoral (4207) access for coronary angiography and percutaneous coronary intervent

100 ts at 5 sites eligible to undergo diagnostic coronary angiography and percutaneous coronary intervent

101 and Percutaneous Coronary Intervention) for coronary angiography and percutaneous coronary intervent

102 Coronary angiography and percutaneous intervention rely

103 mly assigned to radial or femoral access for coronary angiography and percutaneous intervention, and

104 nvasive management strategy (including early coronary angiography and revascularisation) for non-ST-e

105 Subsequent rates of coronary angiography and revascularization after stress

106 Significant heterogeneity for invasive coronary angiography and revascularization was noted, wh

107 0.001, versus lipid screening) and increased coronary angiography and revascularization.

108 especially those without STE, do not undergo coronary angiography and revascularization.

109 s using all available information, including coronary angiography and serial levels of high-sensitivi

110 -82 years]; 52% male) underwent conventional coronary angiography and were compared with age- and sex

111 nderwent cardiac magnetic resonance imaging, coronary angiography, and invasive hemodynamic assessmen

112 those tested, only 5.9% underwent subsequent coronary angiography, and only 3.1% underwent repeat rev

113 >/=1 diagnostic imaging test, most commonly coronary angiography, and only 9 (2.6%) underwent target

114 ECLS, coronary angiography, and percutaneous coronary interven

115 ata, 12-lead ECG, 12-hour Holter recordings, coronary angiography, and serial plasma levels of high-s

116 years, presumably due to an increased use of coronary angiography, and the clinical availability and

117 oronary intervention included in the Swedish Coronary Angiography Angioplasty Registry (SCAAR) betwee

118 Significant CAD was defined by invasive coronary angiography as >50% stenosis of the left main s

119 ved the diagnostic performance of MPI, using coronary angiography as a reference standard.

120 ical outcome of patients with ACS undergoing coronary angiography, as compared with patients with sta

121 zed HFpEF patients (EF >/=50%) who underwent coronary angiography at Duke University Medical Center f

122 P = 0.06), noninvasive tests were as good as coronary angiography at predicting cardiovascular mortal

123 Noninvasive tests are as good as coronary angiography at predicting future adverse cardio

124 riodontal parameters in patients assigned to coronary angiography because of cardiologic problems, wh

125 S trial based on whether or not patients had coronary angiography before treatment was chosen.

126 erenhancement-magnetic resonance imaging and coronary angiography between 2002 and 2006.

127 of atherosclerotic CAD detected by elective coronary angiography between 2012 and 2014.

128 consecutive patients with ACS who underwent coronary angiography between July 2006 and March 2008 in

129 n nondiabetic patients referred for invasive coronary angiography but not in symptomatic patients ref

130 severity was quantified in each subject via coronary angiography by calculating a CAD score.

131 ated with the presence of CAV at the time of coronary angiography by using multivariate logistic regr

132 ulations on patients' radiation doses during coronary angiography (CA) and PCI and temporal trends ar

133 sion computed tomography (SPECT) relative to coronary angiography (CA) for assessment of coronary art

134 The use of coronary angiography (CA) for diagnosis and management o

135 Although invasive coronary angiography (CA) remains the gold standard for

136 gistry of Acute Coronary Events) score >140, coronary angiography (CAG) is recommended by European an

137 After coronary angiography (CAG), the proximal, mid, and dista

138 with stable chest pain and planned invasive coronary angiography, care guided by CTA and selective F

139 opathy (CAV) in comparison with conventional coronary angiography (CCAG) alone or with intravascular

140 AF and 7,159 unaffected individuals from two coronary angiography cohorts and a cohort comprising pat

141 CSA during coronary angiography could effectively remove more than

142 ients were subjected to CSA procedure during coronary angiography (CSA group), and 25 patients served

143 dual-source (256-slice) computed tomography coronary angiography (CTA) for any reason in our cardiac

144 Computed tomography coronary angiography (cTCA) and stress cardiac magnetic

145 rowing >/=50% on visual computed tomographic coronary angiography (CTCA) are generally considered for

146 ulness of screening with computed tomography coronary angiography (CTCA), and assess the safety and e

147 visual estimation (DSVE) and by quantitative coronary angiography (DSQCA) was compared with FFR.

148 ive management pathway initiated by invasive coronary angiography during their hospitalization and up

149 They underwent coronary angiography, endothelial function testing; meas

150 The color-coded display of FFR values during coronary angiography facilitates the integration of phys

151 Patients prospectively underwent coronary angiography followed by coronary intravascular

152 an important determinant of the provision of coronary angiography following NSTE-ACS.

153 he long-term outcomes of patients undergoing coronary angiography for acute coronary syndrome (ACS) o

154 METHODS AND Adults who underwent coronary angiography for acute ST-segment-elevation and

155 study of all US veterans undergoing elective coronary angiography for CAD between October 2007 and Se

156 al registry of real-life patients undergoing coronary angiography for clinically indicated reasons (n

157 To assess the diagnostic value of MDCT coronary angiography for evaluation of acute chest pain

158 We included all patients who underwent coronary angiography for possible suspected stable ische

159 Among women referred for coronary angiography for signs and symptoms of ischemia,

160 rdiac magnetic resonance (CMR), and invasive coronary angiography for SIHD.

161 way B Vitamin Intervention Trial) undergoing coronary angiography for stable angina pectoris were stu

162 Patients undergoing coronary angiography for suspected coronary heart diseas

163 ion in patients who were undergoing elective coronary angiography for suspected stable angina pectori

164 coronary artery disease (CAD) with elective coronary angiography for suspected stable ischemic heart

165 e studies that compared CT with conventional coronary angiography for the evaluation of the coronary

166 successful targeted temperature management, coronary angiography, formal electrophysiology assessmen

167 valuated all patients who underwent elective coronary angiography from October 2007 to September 2010

168 cant coronary artery disease identified with coronary angiography from the ACTION Registry-GWTG (Get

169 Comparison to quantitative coronary angiography (>/=50%) yielded a prevalence of 65

170 Women referred for coronary angiography had a significantly lower burden of

171 ts with confirmed LMCA stenosis on selective coronary angiography had PCI.

172 Coronary angiography has a Class I recommendation for CA

173 Recently, a high-quality multislice CT coronary angiography has been advocated in the diagnosis

174 coronary artery disease and guide treatment, coronary angiography has many known limitations, particu

175 trials of routine versus selective invasive coronary angiography have high rates of crossover from c

176 erative reconstruction (MBIR) using invasive coronary angiography (ICA) as a standard of reference.

177 h atrial fibrillation (AF) by using invasive coronary angiography (ICA) as the reference method and t

178 ardiac arrest patients referred to immediate coronary angiography (ICA) irrespective of their first p

179 Invasive coronary angiography (ICA) with measurement of fractiona

180 .3% of those receiving UC underwent invasive coronary angiography (ICA), whereas 4.6% of patients und

181 our study; 7 of them also underwent invasive coronary angiography (ICA).

182 timal medical therapy without catheter-based coronary angiography if coronary CT angiography found on

183 echocardiography followed by catheter-based coronary angiography if echocardiography induced mild or

184 ronary artery, and ended with catheter-based coronary angiography if stress imaging induced ischemia

185 ocardial perfusion CT in combination with CT coronary angiography improved the diagnostic accuracy in

186 titative [(15)O]H2O PET imaging and invasive coronary angiography in conjunction with fractional flow

187 to compare CT angiography with conventional coronary angiography in patients with atrial fibrillatio

188 The emergence of noninvasive coronary angiography in patients with suspected coronary

189 ascular care guidelines recommend performing coronary angiography in resuscitated patients after card

190 The use of invasive coronary angiography in stable ischemic heart disease (I

191 n alternative to invasive catheter selective coronary angiography in the diagnosis and long-term foll

192 ximately 1 in 5 patients undergoing elective coronary angiography in the VA had normal coronaries.

193 plications of coronary thrombus, detected by coronary angiography, in a population recruited in all-c

194 Nonselected patients undergoing coronary angiography, in which at least 1 lesion was int

195 Use of coronary angiography increased from 27.2% in 2000 to 43.

196 ed trial of radial versus femoral access for coronary angiography/intervention (N = 7,021), which ove

197 rial, 45 (B1) and 56 patients (B2) underwent coronary angiography, intravascular ultrasound (IVUS), a

198 n (10 male; age range, 9-17 years) underwent coronary angiography, intravascular ultrasound, and MRI.

199 nvasive diagnostic method among quantitative coronary angiography, intravascular ultrasound, optical

200 nt elevation acute coronary syndromes before coronary angiography is a common practice despite an inc

201 Computed tomographic (CT) coronary angiography is a well-established, noninvasive

202 elevation acute coronary syndromes awaiting coronary angiography is associated with excess bleeding

203 dial infarction, it is unknown whether early coronary angiography is associated with improved surviva

204 However, invasive coronary angiography is driven by ongoing symptoms, as w

205 rospective diagnostic accuracy studies of CT coronary angiography is moderate to good, and STARD-adop

206 oronary syndrome or when computed tomography coronary angiography is performed during evaluation of c

207 s, detection is often difficult and invasive coronary angiography is performed routinely.

208 One of the legacies of coronary angiography is to presume that one technique wi

209 d chromatography in 1411 patients undergoing coronary angiography (mean age 63 years, male 66%).

210 nary artery disease (CAD) immediately before coronary angiography, measuring the resistance/height (R

211 Magnetic resonance coronary angiography (MRCA) allows visualization of the

212 this cohort of patients undergoing elective coronary angiography, nonobstructive CAD, compared with

213 y end point was protocol-defined unnecessary coronary angiography (normal fractional flow reserve >0.

214 Early coronary angiography (occurring within one calendar day

215 rson-years of follow-up underwent diagnostic coronary angiography, of whom 281 (40 ST-segment elevati

216 ts completed GES, coronary imaging (invasive coronary angiography or computed tomographic angiography

217 Ninety patients underwent transradial coronary angiography or intervention and were scanned wi

218 Patients undergoing coronary angiography or percutaneous coronary interventi

219 The ulnar artery is rarely selected for coronary angiography or percutaneous coronary interventi

220 , 1.5 [1.1-2.1]), acute (<24 hours) and late coronary angiography (OR, 10 [5.3-22] and 3.8 [2.5-5.7])

221 (stress nuclear or stress echocardiography), coronary angiography, or coronary artery bypass grafting

222 In coronary angiography patients without structural heart d

223 Conclusions and Relevance: Coronary angiography, PCI, and survival to discharge hav

224 in Outcomes and Measures: Temporal trends of coronary angiography, PCI, and survival to discharge in

225 y 2012 and May 2014, 505 patients undergoing coronary angiography, percutaneous coronary intervention

226 Compared with coronary angiography performed soon after recanalization

227 nting a case of critical hand ischemia after coronary angiography performed through radial access des

228 erred to (82)Rb PET MPI followed by invasive coronary angiography performed within 14 days, were stud

229 dobutamine stress echocardiography (DSE) or coronary angiography, performed during preoperative eval

230 aging using PET in conjunction with CT-based coronary angiography (PET/CTCA) enables near-simultaneou

231 ost-mortem CT (PMCT), enhanced with targeted coronary angiography (PMCTA), in adults to avoid invasiv

232 oc analyses, we assessed changes in invasive coronary angiography, preventive treatments, and clinica

233 ences of CCTA-assisted diagnosis on invasive coronary angiography, preventive treatments, and clinica

234 ent study, consisting of 9850 PCI and 10 819 coronary angiography procedures.

235 ference standards were combined quantitative coronary angiography (QCA) and single-photon emission CT

236 fractional flow reserve >0.8 or quantitative coronary angiography [QCA] showing no percentage diamete

237 uced utilization of other stress modalities, coronary angiography, reduced smoking, and greater utili

238 mostasis in patients undergoing transfemoral coronary angiography remains controversial.

239 1 patients for whom reference standard x-ray coronary angiography results were available.

240 ms of subsequent noninvasive tests, invasive coronary angiography, revascularization procedures, cumu

241 roach was used to evaluate the likelihood of coronary angiography, revascularization, and in-hospital

242 ed the effects of this exclusion on rates of coronary angiography, revascularization, and mortality a

243 ce of abnormal myocardial perfusion imaging, coronary angiography, revascularization, and mortality.

244 CT coronary angiography revealed positive coronary artery d

245 who underwent clinically indicated invasive coronary angiography, sensitivities and specificities of

246 Conventional coronary angiography served as the standard of reference

247 METHODS AND When invasive coronary angiography showed CAD, the treatment strategy

248 revealed ST elevation during chest pain and coronary angiography showed coronary vasospasm, which le

249 In 83 patients (13.8%), coronary angiography showed severe CAD that was left unt

250 of coronary artery disease detected on MDCT coronary angiography that were not mirrored by conventio

251 ial blood flow assessment than with invasive coronary angiography, the current clinical surveillance

252 rospective registry of patients referred for coronary angiography, the goal of this study was to deve

253 curacy of CT angiography versus conventional coronary angiography, the sensitivity, specificity, posi

254 e (FFR) is an invasive procedure used during coronary angiography to determine the functional signifi

255 cally stable symptomatic women who underwent coronary angiography to evaluate symptoms and signs of i

256 FFR and quantitative coronary angiography values were known; however, remaine

257 es of normal coronary arteries with elective coronary angiography vary considerably among U.S. commun

258 In patients undergoing transfemoral coronary angiography, VCDs were noninferior to manual co

259 However, similar to invasive coronary angiography, visual CTCA is often inaccurate in

260 The median time from randomization to coronary angiography was 4.5 h (interquartile ratio [IQR

261 tive coronary artery disease by quantitative coronary angiography was 68%.

262 PCI as compared with no coronary angiography was associated with a lower day-30

263 f 1312 propensity score-matched pairs, early coronary angiography was associated with higher odds of

264 caused by VF or pulseless VT, we found early coronary angiography was associated with higher odds of

265 Bleeding before coronary angiography was associated with longer hospital

266 Although there was some evidence that coronary angiography was better at predicting all-cause

267 Selective invasive coronary angiography was considered to be the gold stand

268 Normal coronary angiography was defined as <20% stenosis in all

269 The diagnostic yield of invasive coronary angiography was highest in patients with CAC>40

270 Coronary angiography was performed before ablation in th

271 erpretation was performed months later), and coronary angiography was performed if either result was

272 pitalization (14.6% within 90 days), whereas coronary angiography was performed in 11.1% of patients

273 Intraprocedural coronary angiography was performed in 8 patients.

274 In the ACUITY trial, 3-vessel quantitative coronary angiography was performed in a formal substudy

275 or diameter stenosis >/=80% on quantitative coronary angiography was used as reference standard to d

276 mm Hg), or aggressive therapy with invasive coronary angiography, was recommended based on CCTA find

277 e less than 0.8, as measured during invasive coronary angiography, was the reference for defining sig

278 per-vessel obstructive stenosis by invasive coronary angiography were also compared.

279 D) as defined by ECHO, clinical diagnosis or coronary angiography were eligible for the study.

280 R, coronary CT angiography, and quantitative coronary angiography were evaluated against those of inv

281 CAD or coronary artery disease who underwent coronary angiography were included in this case-control

282 ent CTA, CTP, and FFR assessment on invasive coronary angiography were included.

283 Left ventriculography and coronary angiography were performed to identify LV borde

284 Patients undergoing coronary angiography were recruited into 2 cohorts (1, n

285 Patients who underwent early coronary angiography were younger (59.9 versus 62.0 year

286 raphy by visual estimate and by quantitative coronary angiography when compared with FFR and evaluate

287 with Kawasaki disease and followed up by CT coronary angiography, which provided required excellent

288 serve as an effective gatekeeper to invasive coronary angiography will depend, in part, on the adopti

289 We enrolled 4524 patients undergoing coronary angiography with a 6 French sheath via the comm

290 reliable noninvasive imaging alternative to coronary angiography with an excellent sensitivity, spec

291 f 155 patients with suspected CAD listed for coronary angiography with FFR were prospectively enrolle

292 d computed tomography compared with invasive coronary angiography with fractional flow reserve for th

293 y manifestation, with indications to undergo coronary angiography with intent to perform percutaneous

294 with a history of ASA sensitivity undergoing coronary angiography with intent to undergo percutaneous

295 Preimplantation coronary angiography with simultaneous test angioplasty

296 r case it can be stated that high-quality CT coronary angiography with the use of multi-slice dual so

297 troponin level who were scheduled to undergo coronary angiography within 2 to 48 hours after randomiz

298 We also analyzed a subgroup who underwent coronary angiography within 30 days after positive DSE.

299 All patients underwent control coronary angiography within 4 wk, which served as the re

300 thout coronary angiography, 615 (35.7%) with coronary angiography without PCI, and 479 (27.8%) with b